Agomab Therapeutics NV — 6-K Filings

2 6-K filings on record

This page lists all 6-K filings submitted to the SEC by Agomab Therapeutics NV (AGMB), sorted by most recent first. Each row links to the full filing on EdgarLookup. Agomab Therapeutics NV has filed 2 6-K documents with the SEC since 2024. To view all SEC filings by Agomab Therapeutics NV, see the full filings list.

Overview All Filings Financials Insiders

All 3 424B4 6-K 8-A12B CERT DRS DRS/A EFFECT F-1 F-1/A S-8 SCHEDULE 13D SCHEDULE 13G

Form	Description	Accession Number	Filed	Period
6-K	FORM 6-K	0001104659-26-024095	Mar 5, 2026	—
6-K	FORM 6-K	0001104659-26-012080	Feb 9, 2026	—